E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/23/2019 in the Prospect News Emerging Markets Daily.

S&P lifts YanAn to CCC+

S&P said it raised the long-term issuer credit rating on YanAn Bicon Pharmaceutical Listed Co. to CCC+ from CCC.

The agency also said it removed the rating from CreditWatch, where it was placed with developing implications in November.

The outlook is negative.

The upgrades reflect a reduced risk of an immediate default owing to YanAn Bicon's refinancing of its puttable bonds in December 2018, the agency explained.

YanAn Bicon still faces significant liquidity risk, S&P said.

The company has sizable debt maturities over the next 12- to 24-months, the agency said, and it is expected to have negative free cash flows over the period.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.